Resveratroloside

Resveratroloside (Resveratrol glycoside) is an orally active competitive inhibitor of α-glucosidase. Resveratroloside has hypoglycemic and cardioprotective effects. Resveratroloside can be used for the research of diabetes and heart system diseases[1][2].

Product Specifications

CAS Number

[38963-95-0]

Product Name Alternative

Resveratrol glycoside; trans-Resveratrol 4'-O-β-D-glucopyranoside

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Glycosidase

Type

Natural Products

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease; Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/resveratroloside.html

Purity

99.88

Solubility

DMSO : 200 mg/mL (ultrasonic)

Smiles

OC1=CC(O)=CC(/C=C/C(C=C2)=CC=C2O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO)=C1

Molecular Formula

C20H22O8

Molecular Weight

390.38

Precautions

H315, H319, H335

References & Citations

[1]Zhao X, et al. Resveratroloside Alleviates Postprandial Hyperglycemia in Diabetic Mice by Competitively Inhibiting α-Glucosidase. J Agric Food Chem. 2019 Mar 13;67 (10) :2886-2893.|[2]Naumenko SE, et al. Cardioprotective effect of resveratrol and resveratroloside. Cardiovasc Hematol Agents Med Chem. 2013 Sep;11 (3) :207-10.